OMass Therapeutics

At OMass Therapeutics, we are identifying new medicines against highly validated but inadequately drugged targets using novel biochemistry techniques, native mass spectrometry and custom chemistry. We distil biology to its essential elements – physical interactions within a native ecosystem – to deliver cell-system fidelity and cell-free precision. OMass is identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes. We are advancing a pipeline of small molecule therapeutics in orphan diseases and immunological conditions, targeting solute carriers, inflammasome complexes and GPCRs. We preserve the fidelity of the native target ecosystem outside the confounding complexity of the cell to precisely interrogate the fundamental interactions that drive life.